Compare ATOS & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOS | DAIO |
|---|---|---|
| Founded | 2009 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 28.2M |
| IPO Year | 2010 | 2026 |
| Metric | ATOS | DAIO |
|---|---|---|
| Price | $2.27 | $2.90 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.67 | N/A |
| AVG Volume (30 Days) | ★ 47.2K | 18.8K |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,758.00 | ★ $21,500,000.00 |
| Revenue This Year | N/A | $3.26 |
| Revenue Next Year | N/A | $25.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.53 | $2.16 |
| 52 Week High | $7.56 | $4.49 |
| Indicator | ATOS | DAIO |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 53.53 |
| Support Level | $2.05 | $2.85 |
| Resistance Level | $2.60 | $3.30 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 39.17 | 62.69 |
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.